Literature DB >> 15037705

Devic disease and thymoma with anti-central nervous system and antithymus antibodies.

J C Antoine1, J P Camdessanché, L Absi, F Lassablière, L Féasson.   

Abstract

A patient with myasthenia gravis and thymoma developed neuromyelitis optica (NMO) and necrotizing myositis 4 months after treatment of the tumor. Antibodies reacting with the CNS and thymic epithelial cells were detected in the serum during the acute phase of NMO, suggesting that the NMO was linked to the thymoma.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15037705     DOI： 10.1212/01.wnl.0000115168.73299.88

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  11 in total

1.  Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies.

Authors:  François Ducray; Richard Roos-Weil; Pierre Yves Garcia; Juliana Slesari; Olivier Heinzlef; Denis Chatelain; Philippe Toussaint; Etienne Roullet; Jérôme Honnorat
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03       Impact factor: 10.154

2.  An epidemiological study of neuromyelitis optica in Cuba.

Authors:  Jose A Cabrera-Gómez; John F Kurtzke; Alina González-Quevedo; R Lara-Rodríguez
Journal:  J Neurol       Date:  2009-02-09       Impact factor: 4.849

3.  Is neuromyelitis optica with advanced age of onset a paraneoplastic disorder?

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Int J Neurosci       Date:  2013-10-31       Impact factor: 2.292

4.  Clinical characteristics of autoimmune disorders in the central nervous system associated with myasthenia gravis.

Authors:  Kimitoshi Kimura; Yoichiro Okada; Chihiro Fujii; Kenichi Komatsu; Ryosuke Takahashi; Sadayuki Matsumoto; Takayuki Kondo
Journal:  J Neurol       Date:  2019-07-24       Impact factor: 4.849

Review 5.  Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies.

Authors:  Julien Ratelade; A S Verkman
Journal:  Int J Biochem Cell Biol       Date:  2012-06-17       Impact factor: 5.085

6.  New insights into neuromyelitis optica.

Authors:  Woojun Kim; Su-Hyun Kim; Ho Jin Kim
Journal:  J Clin Neurol       Date:  2011-09-29       Impact factor: 3.077

7.  Paraneoplastic neuromyelitis optica associated with ANNA-1 antibodies in invasive thymoma.

Authors:  Hee Kyung Yang; Se Joon Woo; Woong-Yang Park; Jeong-Min Hwang
Journal:  BMC Ophthalmol       Date:  2014-09-03       Impact factor: 2.209

8.  Inflammatory myopathy with myasthenia gravis: Thymoma association and polymyositis pathology.

Authors:  Naohiro Uchio; Kenichiro Taira; Chiseko Ikenaga; Masato Kadoya; Atsushi Unuma; Kenji Yoshida; Setsu Nakatani-Enomoto; Yuki Hatanaka; Yasuhisa Sakurai; Yasushi Shiio; Kenichi Kaida; Akatsuki Kubota; Tatsushi Toda; Jun Shimizu
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-12-24

9.  A Case of Primary Central Nervous System Lymphoma Mimic Neuromyelitis Optica.

Authors:  Xixi Sheng; Mingwei Xu; Xia Li
Journal:  Transl Neurosci       Date:  2020-02-18       Impact factor: 1.757

Review 10.  Neuromyelitis optica pathogenesis and aquaporin 4.

Authors:  David J Graber; Michael Levy; Douglas Kerr; William F Wade
Journal:  J Neuroinflammation       Date:  2008-05-29       Impact factor: 8.322
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.